Aortic Aneurysm Market Forecast: 10.8% CAGR to Hit USD 10.87 Billion by 2032

Overview

The Global Aortic Aneurysm Market was valued at USD 4 billion in 2022 and is projected to reach USD 10.87 billion by 2032, expanding at a CAGR of 10.8% from 2023 to 2032. Market expansion is largely driven by the growing prevalence of cardiovascular disorders. Conditions such as hypertension, obesity, and smoking contribute to arterial wall weakening, increasing the likelihood of aneurysm formation. The continuous rise in these risk factors supports the growing need for diagnosis and treatment worldwide.

Technological advancements in endovascular procedures are transforming the treatment landscape. The introduction of minimally invasive techniques such as endovascular aneurysm repair (EVAR) has improved clinical outcomes by minimizing surgical risks and shortening recovery periods. Ongoing innovations in stent grafts, imaging systems, and delivery devices have enhanced procedural precision. These developments are broadening clinical acceptance and driving adoption across healthcare facilities.

Rising awareness and early diagnosis have further accelerated market growth. The increasing availability of advanced imaging technologies, including CT and MRI, enables timely detection in high-risk populations. Early identification of aneurysms supports preventive treatment strategies and reduces mortality rates. Awareness campaigns by healthcare organizations are encouraging regular health checkups, strengthening the diagnostic and therapeutic demand base.

The expanding geriatric population is another critical factor contributing to market growth. Aging leads to vascular degeneration, which raises susceptibility to aneurysm formation. With the global elderly population increasing rapidly, the demand for continuous monitoring and treatment of aortic aneurysms is expected to rise significantly. This demographic trend ensures steady market demand throughout the forecast period.

Improvements in healthcare infrastructure and favorable regulatory frameworks are enhancing market accessibility. Investments in hospital modernization, training programs for vascular specialists, and supportive reimbursement policies are fostering wider adoption of endovascular procedures. Additionally, strong R&D activities and strategic collaborations among medical device manufacturers and research institutions are fueling innovation. These efforts are expected to enhance device performance, support technological evolution, and sustain long-term market growth.

Key Takeaways

• The aortic aneurysm market is projected to grow at a CAGR of 10.8% from 2023 to 2032, reaching approximately USD 10.87 billion.
• By 2050, around 16% of the global population will be aged over 65, driving higher demand for aortic aneurysm treatments.
• Cardiovascular diseases accounted for 19.1 million global deaths in 2020, significantly increasing the need for effective aortic aneurysm interventions.
• The adoption of minimally invasive surgical procedures is rising, as these techniques enable faster recovery and shorter hospital stays for patients.
• The market is segmented by aneurysm type (TAA, AAA), device type (stent-grafts, catheters), and procedures such as OSR and EVAR.
• North America dominates the global market with over 51% share, supported by advanced healthcare infrastructure and high diagnosis rates.
• The Asia-Pacific region exhibits the fastest growth due to its expanding elderly population and increasing healthcare investments.

Regional Analysis

North America is anticipated to dominate the aortic aneurysm market, accounting for over 51% of the total revenue share during the forecast period. The region’s growth is driven by its well-established healthcare infrastructure and strong adoption of advanced medical technologies. Additionally, favorable reimbursement policies and the presence of key market players support market expansion. Government initiatives focused on early detection and improved treatment of aortic aneurysms are further fueling market revenue growth across the region during the projection period.

The United States holds the largest share within North America, supported by advanced diagnostic capabilities and increasing awareness of cardiovascular conditions. Continuous research and development activities, along with technological innovation in endovascular repair devices, strengthen market growth. Rising healthcare expenditure and growing patient preference for minimally invasive procedures also contribute to the region’s dominance. These factors collectively position North America as the leading contributor to global market revenue during the forecast timeframe.

The Asia Pacific region is projected to experience the fastest growth in the aortic aneurysm market over the forecast period. The expansion is attributed to the rapidly aging population and rising incidence of cardiovascular diseases (CVDs). Increasing healthcare spending and the adoption of advanced medical devices are driving market growth. Furthermore, government programs promoting healthcare modernization and awareness about early aneurysm diagnosis support the rising demand for aortic aneurysm treatments in the region.

Countries such as China, India, and Japan are emerging as high-growth markets within the Asia Pacific region. Improving healthcare infrastructure and rising investments in medical technology are key contributors to market development. The growing availability of skilled healthcare professionals and advanced surgical facilities further enhances treatment adoption. Government initiatives focusing on improving accessibility to endovascular procedures are likely to strengthen the regional market outlook. As a result, the Asia Pacific market is expected to register the highest compound annual growth rate during the forecast period.

Segmentation Analysis

Abdominal aortic aneurysm (AAA) dominates the aortic aneurysm market due to its higher prevalence compared to thoracic aortic aneurysm (TAA). AAA often develops below the kidneys, particularly in the pararenal region. According to a Circulation article, around 2.5% of individuals aged above 65 years are affected by AAA. In contrast, TAA cases occur only 4.5%–5.9% per 100,000 person-years. Increasing research and development initiatives and favorable government support for advanced device approvals are propelling the growth of this segment globally.

Stent grafts are experiencing significant demand due to technological innovations in design and function. Manufacturers are launching advanced systems integrated with imaging to enhance treatment outcomes. These devices are increasingly preferred for intravascular aneurysm repair, offering improved safety and efficiency. For example, Terumo Corporation initiated the PANTHER project in September 2021 to study surgical graft technologies. Such advancements, coupled with ongoing clinical research, are expected to drive substantial expansion in the stent graft segment during the forecast period.

Endovascular aneurysm repair (EVAR) is projected to register the fastest growth rate among treatment types. This minimally invasive technique is widely adopted for treating abdominal aortic aneurysms, offering reduced recovery time and hospitalization. Technological advancements supporting EVAR are minimizing procedural risks and improving patient outcomes. According to Endologix, 75% of aneurysm repairs in the U.S. in 2017 were performed using EVAR. Furthermore, the demand for open surgical repair continues in developing economies due to cost-effectiveness and limited access to advanced medical technologies.

Hospitals and clinics account for the largest share of end-users in the aortic aneurysm market. These facilities possess the infrastructure and expertise necessary for complex surgical procedures. Moreover, favorable reimbursement policies encourage treatment adoption in hospital settings. Ambulatory surgical centers, however, are witnessing rapid growth owing to shorter recovery times and reduced overall costs. Increasing awareness regarding early diagnosis and treatment of aortic aneurysms, particularly in developed economies, is expected to further strengthen the growth of both end-user segments.

Key Players Analysis

The aortic aneurysm market is moderately competitive due to the presence of several established and emerging players. Many companies are focusing on enhancing their product portfolios through innovation and technological advancements. The rising adoption of minimally invasive procedures and endovascular repair devices has encouraged firms to strengthen their market presence. Investments in research and development are expected to support the introduction of next-generation stent graft systems, driving growth opportunities for both global and regional participants during the forecast period.

Leading companies such as Cardinal Health, Medtronic, and Terumo Corporation are expanding their product offerings to meet the growing demand for efficient aneurysm repair devices. These players are leveraging strong distribution networks and clinical expertise to maintain market dominance. Continuous product innovation and extensive clinical trials are helping them strengthen their brand value. Furthermore, their strategic focus on long-term collaborations with healthcare institutions enhances accessibility and improves patient outcomes in the treatment of aortic aneurysms.

In addition, manufacturers like MicroPort Scientific Corporation, Cook Medical, and Gore & Associates Inc. are focusing on mergers, acquisitions, and partnerships to expand their geographic footprint. These firms are also developing innovative stent graft systems with improved durability and flexibility. Such efforts aim to address the rising prevalence of cardiovascular diseases and enhance procedural success rates. The adoption of precision-based medical technologies is expected to reinforce their competitive advantage and increase their market share across developed and emerging regions.

Other notable participants, including Endologix Inc., Jotec GmbH, Cryolife Inc., and LivaNova PLC, are strengthening their product pipelines and regulatory approvals. These companies emphasize strategic alliances and targeted acquisitions to accelerate product commercialization. Their initiatives toward patient-centric device development and cost-efficient production models are fostering sustainable market growth. With continued innovation and a growing emphasis on personalized healthcare solutions, the competitive landscape of the aortic aneurysm market is expected to evolve significantly in the coming years.

Market Key Players

• Cardinal Health
• Medtronic
• Terumo Corporation
• MicroPort Scientific Corporation
• Cook Medical
• Gore & Associates Inc.
• Endologix Inc.
• Jotec GmbH
• Cryolife Inc.
• LivaNova PLC
• Other Key Players

Conclusion

The global aortic aneurysm market is expected to grow steadily, driven by the increasing cases of cardiovascular diseases and the rising elderly population. Advancements in minimally invasive procedures like endovascular aneurysm repair are making treatments safer and more effective. Continuous innovations in stent grafts and diagnostic imaging are improving patient outcomes and expanding adoption worldwide. Supportive healthcare policies, growing awareness about early diagnosis, and improved medical infrastructure are further boosting market expansion. With strong participation from leading manufacturers and ongoing R&D efforts, the aortic aneurysm market is set to experience consistent growth, supported by technological progress and a growing focus on patient-centered treatment solutions.

Get in Touch with Us:
Market.us (Powered By Prudour Pvt. Ltd.)
Address: 420 Lexington Avenue, Suite 300, New York City, NY 10170, United States.
Contact No: +1 718 874 1545 (International), +91 78878 22626 (Asia).
Email: [email protected]